SCHEMBL7355950

SCHEMBL7355950

CCCCCNC(CC(N)=O)C(N)=O

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 1/20 0.40
DPP7 Q9UHL4 2/20 0.40
EPHX1 P07099 9/20 0.39
ALOX15 P16050 1/20 0.38
ECE1 P42892 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
RRM1 P23921 1/20 0.37
CASP2 P42575 1/20 0.36
MEN1 O00255 1/20 0.35
FAAH O00519 1/20 0.35
TP53 P04637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
SOAT1 P35610 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1045359 0.98 EPHX1 (0.42) NOD1DPP7EPHX1ALOX15RRM1
SCHEMBL29697582 0.98 EPHX1 (0.42) NOD1DPP7EPHX1ALOX15RRM1
SCHEMBL29364715 0.98 EPHX1 (0.42) NOD1DPP7EPHX1ALOX15RRM1
SCHEMBL2692730 0.98 EPHX1 (0.42) NOD1DPP7EPHX1ALOX15RRM1
SCHEMBL1045358 0.98 EPHX1 (0.42) NOD1DPP7EPHX1ALOX15RRM1
SCHEMBL23831532 0.98 EPHX1 (0.42) NOD1DPP7EPHX1ALOX15RRM1
SCHEMBL29697562 0.94 ALOX15 (0.44) NOD1DPP7EPHX1ALOX15ECE1
SCHEMBL4285744 0.87 NOD1 (0.48) NOD1DPP7EPHX1ALOX15ECE1
SCHEMBL4285748 0.87 NOD1 (0.48) NOD1DPP7EPHX1ALOX15ECE1
SCHEMBL3261071 0.86 ECE1 (0.40) ALOX15ECE1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1005448-A2 NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FOR THE TREATMENT OF ARTHRITIS Du Pont Pharmaceuticals Company (US) 2000-06-07 EP disclosed
WO-1999009000-A2 NOVEL INHIBITORS OF AGGRECANASE AND MATRIX METALLOPROTEINASES FOR THE TREATMENT OF ARTHRITIS DU PONT PHARMACEUTICALS COMPANY (US) 1999-02-25 WO disclosed